ClinVar Miner

Submissions for variant NM_000642.3(AGL):c.4347+1G>C

dbSNP: rs1553193463
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001243974 SCV001417166 pathogenic Glycogen storage disease type III 2019-11-22 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in AGL are known to be pathogenic (PMID: 19299494). Experimental studies have shown that disruption of this splice site disrupts mRNA splicing (PMID: 26984562). Disruption of this splice site has been observed in individual(s) with glycogen storage disease (PMID: 26984562). This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 32 of the AGL gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. Please be sure to change the variant details text from "This variant has been" to "Disruption of this splice site has been" for that E3 text.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.